Extract

• To evaluate the time to onset of moderate-severe persistent paresthesic positive symptoms of chemotherapy-induced neuropathy defined as a minimum score ≥ 4 assessed with the Numeric Rating Scale (NRS) from the onset of chemotherapy or emergence of a chemotherapy dose reduction or delay of chemotherapy cycle due to severity of chemotherapy-induced neuropathy. The persistent paresthesic positive symptoms will be measured by a modified NRS (Numeric Rating Scale) which assesses paresthesia rather than pain.

Inclusion criteria

• CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY SYMPTOMS

Links

• euctr
• ictrp
• ictrp
• euctr